{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:13:37Z","timestamp":1767831217669,"version":"3.49.0"},"reference-count":55,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Personalized Medicine"],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.2217\/pme-2023-0137","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T11:59:05Z","timestamp":1706270345000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-8819","authenticated-orcid":false,"given":"Carlen A","family":"Yuen","sequence":"first","affiliation":[{"name":"Department of Neuro-Oncology, University of California, Irvine, CA 92868-3201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silin","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine. Community Regional Medical Center, Fresno, CA\u00a093721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mya Sandi","family":"Aung","sequence":"additional","affiliation":[{"name":"California Health Sciences University, College of Osteopathic Medicine, Clovis, CA\u00a093611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Shishodia","sequence":"additional","affiliation":[{"name":"California Health Sciences University, College of Osteopathic Medicine, Clovis, CA\u00a093611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Tang","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, University of California, Irvine, CA 92868-3201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001784"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.01.023"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2018.05.001"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002766"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003507"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab107"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.02.023"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12930"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7549"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204924"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0295"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa008"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25055"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-430140"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51014"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000001076"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.935090"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1318237"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.07.034"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019649201324"},{"issue":"2","key":"e_1_3_6_22_1","first-page":"621","article-title":"Erdheim-Chester disease and concomitant tuberculosis successfully treated with chemotherapy and long-term steroids","volume":"31","author":"Badzek S","year":"2007","unstructured":"Badzek S, Misir-Krpan A, Krajina Z, Radman I, Stern-Padovan R, Dotlic S. Erdheim-Chester disease and concomitant tuberculosis successfully treated with chemotherapy and long-term steroids. Coll Antropol 31(2), 621\u2013623 (2007).","journal-title":"Coll Antropol"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01288"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.11.1"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-294108"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-446286"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000832"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-561381"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0988-y"},{"issue":"20","key":"e_1_3_6_30_1","doi-asserted-by":"crossref","first-page":"e2746","DOI":"10.1212\/WNL.0000000000010748","article-title":"Central nervous system involvement in Erdheim-Chester disease: an observational cohort study","volume":"95","author":"Cohen Aubart F","year":"2020","unstructured":"Cohen Aubart F, Idbaih A, Galanaud D et al. Central nervous system involvement in Erdheim-Chester disease: an observational cohort study. Neurology 95(20), e2746\u2013e2754 (2020).","journal-title":"Neurology"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0944-4"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5029"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1135-7"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2382041525"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000422"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30219-3"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.1950"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000078"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.192195"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30429-1"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201475"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1713"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758834014566428"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.185298"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241143"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.3171\/2018.6.PEDS17728"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771873"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100984"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2022.2087232"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.07.005"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000401"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000866"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-740217"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067583"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00087-X"},{"issue":"1","key":"e_1_3_6_56_1","first-page":"vdaa024","article-title":"Dual BRAF\/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy","volume":"2","author":"Mazor RD","year":"2020","unstructured":"Mazor RD, Weissman R, Luckman J et al. Dual BRAF\/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy. Neurooncol Adv 2(1), vdaa024 (2020).","journal-title":"Neurooncol Adv"}],"container-title":["Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pme-2023-0137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T20:00:29Z","timestamp":1727208029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pme-2023-0137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6,6]]}},"alternative-id":["10.2217\/pme-2023-0137"],"URL":"https:\/\/doi.org\/10.2217\/pme-2023-0137","relation":{},"ISSN":["1741-0541","1744-828X"],"issn-type":[{"value":"1741-0541","type":"print"},{"value":"1744-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}